We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
+0.3%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$13.9B
AUM Growth
-$512M
Cap. Flow
-$427M
Cap. Flow %
-3.07%
Top 10 Hldgs %
13.98%
Holding
2,837
New
70
Increased
591
Reduced
1,041
Closed
180

Sector Composition

Rank Sector Weight
1 Technology 13.1%
2 Financials 12.77%
3 Healthcare 11.82%
4 Energy 11.39%
5 Industrials 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRWD icon
1176
Ironwood Pharmaceuticals
IRWD
$714M
$1.2M 0.01%
110,188
CCOI icon
1177
Cogent Communications
CCOI
$525M
$1.19M 0.01%
35,423
COHR
1178
DELISTED
Coherent Inc
COHR
$1.19M 0.01%
19,411
RYAM icon
1179
Rayonier Advanced Materials
RYAM
$561M
$1.19M 0.01%
+36,130
New +$1.27M
RPT
1180
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$1.19M 0.01%
73,171
+6,464
+10% +$108K
ENV
1181
DELISTED
ENVESTNET, INC.
ENV
$1.18M 0.01%
26,306
NKTR icon
1182
Nektar Therapeutics
NKTR
$2.57B
$1.18M 0.01%
6,528
MGLN
1183
DELISTED
Magellan Health Services, Inc.
MGLN
$1.18M 0.01%
21,592
CATM
1184
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$1.18M 0.01%
33,582
PNK
1185
DELISTED
Pinnacle Entertainment Inc.
PNK
$1.18M 0.01%
47,086
-1,555
-3% -$38.1K
CVBF icon
1186
CVB Financial
CVBF
$4.05B
$1.18M 0.01%
81,895
TFM
1187
DELISTED
THE FRESH MARKET, INC COM STK
TFM
$1.18M 0.01%
33,628
WMGI
1188
DELISTED
Wright Medical Group Inc
WMGI
$1.17M 0.01%
38,601
AUXL
1189
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$1.16M 0.01%
38,949
-305
-0.8% -$6.46K
BGS icon
1190
B&G Foods
BGS
$291M
$1.16M 0.01%
41,999
VGR
1191
DELISTED
Vector Group Ltd.
VGR
$1.16M 0.01%
93,868
-2
-0% -$23
LTC
1192
LTC Properties
LTC
$2.1B
$1.15M 0.01%
31,112
-3,695
-11% -$145K
GTAT
1193
DELISTED
GT ADVANCED TECHNOLOGIES INC COM STK (DE)
GTAT
$1.15M 0.01%
105,894
THRM icon
1194
Gentherm
THRM
$1.27B
$1.14M 0.01%
27,101
GEVA
1195
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$1.14M 0.01%
16,585
TIVO
1196
DELISTED
TIVO INC
TIVO
$1.14M 0.01%
88,961
CJES
1197
DELISTED
C&J ENERGY SVCS LTD
CJES
$1.13M 0.01%
37,099
ADEA icon
1198
Adeia
ADEA
$3.16B
$1.13M 0.01%
160,968
MDCO
1199
DELISTED
Medicines Co
MDCO
$1.13M 0.01%
50,677
ABM icon
1200
ABM Industries
ABM
$2.84B
$1.13M 0.01%
43,931

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q3 2014 Portfolio in Review

As of Q3 2014, Metropolitan Life Insurance Company (MetLife) held 2,837 positions worth $13.9B, down 3.6% from $14.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Metropolitan Life Insurance Company (MetLife) withdrew a net $427M in Q3 2014, closing 180 positions and reducing 1,041 holdings. Its most notable exit was Accenture, an estimated $31.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in Monsanto Co worth $35.2M.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2014 buy was Monsanto Co: 313,199 shares worth $35.2M.
  • Metropolitan Life Insurance Company (MetLife) added most to Microsoft in Q3 2014, an estimated $14M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $22.5M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Accenture in Q3 2014, selling an estimated $31.6M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 14% of its $13.9B portfolio in Q3 2014.
  • Metropolitan Life Insurance Company (MetLife) opened 70 new positions and closed 180 in Q3 2014.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 3.6% quarter-over-quarter to $13.9B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2014, filed 10 Nov 2014.